1. Home
  2. CION vs BVS Comparison

CION vs BVS Comparison

Compare CION & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CION
  • BVS
  • Stock Information
  • Founded
  • CION 2011
  • BVS 2011
  • Country
  • CION United States
  • BVS United States
  • Employees
  • CION N/A
  • BVS N/A
  • Industry
  • CION Finance/Investors Services
  • BVS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • CION Finance
  • BVS Health Care
  • Exchange
  • CION Nasdaq
  • BVS Nasdaq
  • Market Cap
  • CION 521.7M
  • BVS 462.5M
  • IPO Year
  • CION N/A
  • BVS 2021
  • Fundamental
  • Price
  • CION $10.07
  • BVS $6.57
  • Analyst Decision
  • CION Sell
  • BVS Strong Buy
  • Analyst Count
  • CION 2
  • BVS 5
  • Target Price
  • CION $11.00
  • BVS $14.40
  • AVG Volume (30 Days)
  • CION 242.9K
  • BVS 468.3K
  • Earning Date
  • CION 08-07-2025
  • BVS 08-05-2025
  • Dividend Yield
  • CION 14.31%
  • BVS N/A
  • EPS Growth
  • CION N/A
  • BVS N/A
  • EPS
  • CION N/A
  • BVS N/A
  • Revenue
  • CION $234,952,000.00
  • BVS $567,699,000.00
  • Revenue This Year
  • CION N/A
  • BVS N/A
  • Revenue Next Year
  • CION N/A
  • BVS $6.11
  • P/E Ratio
  • CION N/A
  • BVS N/A
  • Revenue Growth
  • CION N/A
  • BVS 8.60
  • 52 Week Low
  • CION $8.51
  • BVS $6.02
  • 52 Week High
  • CION $12.71
  • BVS $14.38
  • Technical
  • Relative Strength Index (RSI)
  • CION 62.12
  • BVS 47.42
  • Support Level
  • CION $10.01
  • BVS $6.81
  • Resistance Level
  • CION $10.27
  • BVS $6.59
  • Average True Range (ATR)
  • CION 0.16
  • BVS 0.29
  • MACD
  • CION 0.02
  • BVS -0.04
  • Stochastic Oscillator
  • CION 69.70
  • BVS 26.27

About CION CION Investment Corporation

CION Invt Corp is an externally managed, non-diversified, closed-end management investment company that has elected to be regulated as a business development company. The Company's portfolio is comprised of investments in senior secured debt, including first lien loans, second lien loans, and unitranche loans, and, to a lesser extent, collateralized securities, structured products and other similar securities, unsecured debt, and equity, of private and thinly-traded U.S. middle-market companies. Its investment objective is to generate current income and, to a lesser extent, capital appreciation for investors.

About BVS Bioventus Inc.

Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.

Share on Social Networks: